Gene · 7130
Papers2,523
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
861 to 880 of 2,523
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Adipose-Derived Stem/Stromal Cells in Kidney Transplantation: Status Quo and Future Perspectives. | Int J Mol Sci | 2021 | 34681848 | PubTator, text mining | PubMed |
| Transcriptome Analysis of In Vitro Fertilization and Parthenogenesis Activation during Early Embryonic Development in Pigs. | Genes (Basel) | 2021 | 34680856 | PubTator, text mining | PubMed |
The molecular mechanisms of inflammation and scarring in the kidneys of immunoglobulin A nephropathy : Gene involvement in the mechanisms of inflammation and scarring in kidney biopsy of IgAN patients. | Semin Immunopathol | 2021 | 34674036 | PubTator, text mining | PubMed |
| Redressing the interactions between stem cells and immune system in tissue regeneration. | Biol Direct | 2021 | 34670590 | PubTator, text mining | PubMed |
| MET overexpression contributes to STAT4-PD-L1 signaling activation associated with tumor-associated, macrophages-mediated immunosuppression in primary glioblastomas. | J Immunother Cancer | 2021 | 34667077 | PubTator, text mining | PubMed |
| Therapeutic Potential of Mesenchymal Stromal Cell-Derived Extracellular Vesicles in the Prevention of Organ Injuries Induced by Traumatic Hemorrhagic Shock. | Front Immunol | 2021 | 34659252 | PubTator, text mining | PubMed |
| Current Status of Cell-Based Therapies for COVID-19: Evidence From Mesenchymal Stromal Cells in Sepsis and ARDS. | Front Immunol | 2021 | 34659231 | PubTator, text mining | PubMed |
| Effects of Mesenchymal Stem Cell-Derived Exosomes on Autoimmune Diseases. | Front Immunol | 2021 | 34646275 | PubTator, text mining | PubMed |
| Mesenchymal Stem Cell Transplantation for the Treatment of Age-Related Musculoskeletal Frailty. | Int J Mol Sci | 2021 | 34638883 | PubTator, text mining | PubMed |
| Tumor Necrosis Factor's Pathway in Crohn's Disease: Potential for Intervention. | Int J Mol Sci | 2021 | 34638616 | PubTator, text mining | PubMed |
| Matters of size: Roles of hyaluronan in CNS aging and disease. | Ageing Res Rev | 2021 | 34634492 | PubTator, text mining | PubMed |
| Study on Transorgan Regulation of Intervertebral Disc and Extra-Skeletal Organs Through Exosomes Derived From Bone Marrow Mesenchymal Stem Cells. | Front Cell Dev Biol | 2021 | 34631718 | PubTator, text mining | PubMed |
| Systematic Review of the Application of Perinatal Derivatives in Animal Models on Cutaneous Wound Healing. | Front Bioeng Biotechnol | 2021 | 34631683 | PubTator, text mining | PubMed |
| Empty nose syndrome pathogenesis and cell-based biotechnology products as a new option for treatment. | World J Stem Cells | 2021 | 34630863 | PubTator, text mining | PubMed |
| [Effects of HMGB1 on Proliferation and Secretion of Human Bone Marrow Mesenchymal Stem Cells]. | Zhongguo Shi Yan Xue Ye Xue Za Zhi | 2021 | 34627452 | PubTator, text mining | PubMed |
| Immunotherapy of multisystem inflammatory syndrome in children (MIS-C) following COVID-19 through mesenchymal stem cells. | Int Immunopharmacol | 2021 | 34627083 | PubTator, text mining | PubMed |
| Identification of immunization-related new prognostic biomarkers for papillary renal cell carcinoma by integrated bioinformatics analysis. | BMC Med Genomics | 2021 | 34620162 | PubTator, text mining | PubMed |
| When Origin Matters: Properties of Mesenchymal Stromal Cells From Different Sources for Clinical Translation in Kidney Disease. | Front Med (Lausanne) | 2021 | 34616756 | PubTator, text mining | PubMed |
| In vitro effects of nutraceutical treatment on human osteoarthritic chondrocytes of females of different age and weight groups. | J Nutr Sci | 2021 | 34616553 | PubTator, text mining | PubMed |
| Soluble biological markers in osteoarthritis. | Ther Adv Musculoskelet Dis | 2021 | 34616494 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7130/papers?page=44